Compare Stocks

→ $25,000 into $109,616 in two months? (From WealthPress) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ADAL Anthemis Digital Acquisitions I	$10.47 -0.1%	$10.47	$9.91 ▼ $10.90	$316.07M	0.01	226,140 shs	17,700 shs
AFTR AfterNext HealthTech Acquisition	$10.41	$10.40	$9.70 ▼ $10.60	$325.31M	0.07	48,659 shs	10 shs
DMYS dMY Technology Group, Inc. VI	$10.25	$10.23	$9.71 ▼ $10.75	$317.55M	-0.01	210,860 shs	54,000 shs
MTAC MedTech Acquisition	$11.34	$10.79	$8.43 ▼ $12.83	$83.80M	-0.04	9,656 shs	183,276 shs

12 Stocks Corporate Insiders are Abandoning

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ADAL Anthemis Digital Acquisitions I	0.00%	0.00%	0.00%	0.00%	0.00%
AFTR AfterNext HealthTech Acquisition	0.00%	0.00%	0.00%	0.00%	+1.65%
DMYS dMY Technology Group, Inc. VI	0.00%	0.00%	0.00%	0.00%	0.00%
MTAC MedTech Acquisition	0.00%	0.00%	0.00%	0.00%	+9.88%

SHOCKING Crypto Leak… (Ad)

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ADAL Anthemis Digital Acquisitions I	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
AFTR AfterNext HealthTech Acquisition	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
DMYS dMY Technology Group, Inc. VI	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
MTAC MedTech Acquisition	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ADAL Anthemis Digital Acquisitions I	N/A	N/A	N/A	N/A
AFTR AfterNext HealthTech Acquisition	N/A	N/A	N/A	N/A
DMYS dMY Technology Group, Inc. VI	N/A	N/A	N/A	N/A
MTAC MedTech Acquisition	N/A	N/A	N/A	N/A

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ADAL Anthemis Digital Acquisitions I	N/A	N/A	N/A	N/A	N/A	N/A
AFTR AfterNext HealthTech Acquisition	N/A	N/A	$0.33 per share	31.81	($0.38) per share	N/A
DMYS dMY Technology Group, Inc. VI	N/A	N/A	$0.72 per share	14.31	($0.16) per share	N/A
MTAC MedTech Acquisition	N/A	N/A	$0.89 per share	12.80	($2.04) per share	N/A

Profitability & Earnings

Company	Net Income	EPS	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ADAL Anthemis Digital Acquisitions I	N/A	N/A	∞	N/A	N/A	N/A	N/A	N/A
AFTR AfterNext HealthTech Acquisition	$10.23M	N/A	∞	N/A	N/A	-75.83%	3.47%	N/A
DMYS dMY Technology Group, Inc. VI	$22.20M	N/A	∞	N/A	N/A	-147.40%	9.12%	N/A
MTAC MedTech Acquisition	$5.54M	N/A	∞	N/A	N/A	-17.92%	-1.48%	N/A

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ADAL Anthemis Digital Acquisitions I	N/A	N/A	N/A	N/A	N/A
AFTR AfterNext HealthTech Acquisition	N/A	N/A	N/A	N/A	N/A
DMYS dMY Technology Group, Inc. VI	N/A	N/A	N/A	N/A	N/A
MTAC MedTech Acquisition	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ADAL Anthemis Digital Acquisitions I	N/A	N/A	N/A
AFTR AfterNext HealthTech Acquisition	N/A	0.01	0.01
DMYS dMY Technology Group, Inc. VI	N/A	0.05	0.05
MTAC MedTech Acquisition	N/A	0.03	0.03

Ownership

Institutional Ownership

Company	Institutional Ownership
ADAL Anthemis Digital Acquisitions I	68.28%
AFTR AfterNext HealthTech Acquisition	67.39%
DMYS dMY Technology Group, Inc. VI	65.32%
MTAC MedTech Acquisition	20.96%

Insider Ownership

Company	Insider Ownership
ADAL Anthemis Digital Acquisitions I	23.81%
AFTR AfterNext HealthTech Acquisition	20.00%
DMYS dMY Technology Group, Inc. VI	20.00%
MTAC MedTech Acquisition	76.20%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
ADAL Anthemis Digital Acquisitions I	2,021	30.19 million	23.00 million	Not Optionable
AFTR AfterNext HealthTech Acquisition	2,021	31.25 million	25.00 million	Not Optionable
DMYS dMY Technology Group, Inc. VI	2,021	30.98 million	24.78 million	Not Optionable
MTAC MedTech Acquisition	3	7.39 million	1.95 million	Not Optionable

DMYS, MTAC, AFTR, and ADAL Headlines

Source	Headline
	J&J CEO says M&A strategy ‘will continue’ after medtech megadeals fiercebiotech.com - April 16 at 3:29 PM
	Med-tech deals soar to record high in 2023, digital health still dominates bioworld.com - February 17 at 5:34 PM
	The top medtech trends in 2024 medtechdive.com - January 31 at 1:59 PM
	Johnson & Johnson’s MedTech performance augurs well for industry: analysts msn.com - January 23 at 2:14 PM
	Johnson & Johnson’s earnings beat estimates with boost from medtech sales msn.com - January 23 at 9:13 AM
	5 medtech trends to watch in 2024 medtechdive.com - January 9 at 12:27 PM
	JPM24’s Medtech Tidbits: Acquisitions, approvals, analysis and more fiercebiotech.com - January 9 at 12:27 PM
	20 medtech companies to know, by revenue \| 2023 beckershospitalreview.com - December 28 at 2:07 PM
	The top medtech trends of 2023 massdevice.com - December 20 at 6:00 PM
	5 Tips To Ensure Product-Market Fit In Medtech forbes.com - November 29 at 10:06 AM
	Medical Technology Platform Market Size is expected to reach US$ 54.08 billion at a CAGR of 11.4% by 2030 medgadget.com - November 27 at 9:39 AM
	‘A safe pair of hands’ — Medtech’s investment in Ireland continues to grow massdevice.com - November 20 at 7:43 PM
	Westminster oncology company holds first earnings call since going public bizjournals.com - November 15 at 9:07 PM
	TriSalus Reports Third Quarter 2023 Financial Results and Provides Business Update finance.yahoo.com - November 14 at 10:24 AM
	How can medtech companies innovate their business models? massdevice.com - October 11 at 12:56 PM
	MedTech Innovator announces 2023 Grand Prize winner massdevice.com - October 11 at 12:56 PM
	‘Love, yet fear’ — how medtech is stepping into the digital sphere massdevice.com - October 9 at 6:32 PM
	The Art Of A Profitable Medtech Exit forbes.com - September 25 at 8:30 AM
	Pre-market Movers: MTAC, AYX, DDOG, IFF, CHGG… markets.businessinsider.com - August 8 at 9:04 AM
	MedTech Acquisition Corporation Adjourns Special Meeting of Stockholders finance.yahoo.com - August 3 at 8:55 AM
	Johnson & Johnson posts Q2 beat as Pharma, MedTech outperform msn.com - July 20 at 10:45 AM
	Thermo Fisher to buy real-world evidence company CorEvitas for $913M medtechdive.com - July 7 at 3:35 PM
	FTC Scrutiny Chills Medtech M&A Market mddionline.com - July 5 at 10:06 AM
	How medtech IP can help a startup navigate a ‘brutal’ environment medicaldesignandoutsourcing.com - June 6 at 2:43 PM

Company Descriptions

Anthemis Digital Acquisitions I

NASDAQ:ADAL

Anthemis Digital Acquisitions I Corp does not have significant operations. It focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to focus its efforts in the areas of digital financial services or modern financial technology. The company was incorporated in 2021 and is based in New York, New York.

AfterNext HealthTech Acquisition

NYSE:AFTR

AfterNext HealthTech Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other similar business combination with one or more operating businesses or assets in the healthcare and technology industry. The company was incorporated in 2021 and is based in Fort Worth, Texas.

dMY Technology Group, Inc. VI

NYSE:DMYS

dMY Technology Group, Inc. VI does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to identify a business combination target within the mobile application ecosystem or gaming, enterprise cloud, and consumer internet companies. The company was formerly known as TdMY Technology Group, Inc. and changed its name to dMY Technology Group, Inc. VI in July 2021. dMY Technology Group, Inc. VI was incorporated in 2021 and is based in Las Vegas, Nevada.

MedTech Acquisition

NASDAQ:MTAC

MedTech Acquisition Corporation does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the healthcare sector in the United States. The company was incorporated in 2020 and is based in Greenwich, Connecticut. MedTech Acquisition Corporation operates as a subsidiary of Medtech Acquisition Sponsor LLC.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial